Extracellular Vesicle SEC Columns

Size exclusion chromatography (SEC) column for isolation of extracellular vesicles from biological fluids

Extracellular Vesicle SEC Columns

Size exclusion chromatography (SEC) column for isolation of extracellular vesicles from biological fluids

From: 576 USD
Catalog #
100-0414_C
Size exclusion chromatography (SEC) column for isolation of extracellular vesicles from biological fluids

Product Advantages


  • Fast, easy-to-use protocol

  • Reusable (up to five times)

Products for Your Protocol
To see all required products for your protocol, please consult the Protocols and Documentation.

Overview

Extracellular Vesicle Size Exclusion Chromatography (SEC) Columns are ideal for the isolation and purification of extracellular vesicles (EVs) from numerous types of biological matrices, including plasma, serum, and cell culture media, and provide an efficient method for separation of EVs from circulating proteins. Compared to other methods of EV isolation, SEC columns cause minimal alteration in vesicle characteristics such as functionality and shape. The isolated EVs are suitable for downstream analysis including flow cytometry, western blot, nucleic acid extraction, and/or functional assays.

The EV isolation protocol using the SEC columns is easy and takes approximately 15 minutes. The columns are available in three sizes for different sample volume ranges and can be used up to five times.
Subtype
Size Exclusion Chromatography Columns
Application
Extracellular Vesicle Isolation

Data Figures

Graphs showing the fractions in which particles and proteins, isolated from human plasma using the 0.5 mL Extracellular Vesicle SEC Column, were detected by nanoparticle tracking analysis and bicinchoninic acid assays, respectively.

Figure 1. Isolation of Extracellular Vesicles from Plasma Using a 0.5 mL Extracellular Vesicle SEC Column

The 0.5 mL Extracellular Vesicle SEC Column was loaded with 0.5 mL of human plasma. 100 μL fractions were collected and analyzed for particle and protein content by nanoparticle tracking analysis (NTA) and bicinchoninic acid (BCA) assays, respectively. EVs were detected in fractions 9 - 14, while proteins were detected in fractions 15 onwards.

Graphs showing the fractions in which particles and proteins, isolated from human plasma using the 2 mL Extracellular Vesicle SEC Column, were detected by nanoparticle tracking analysis and bicinchoninic acid assays, respectively.

Figure 2. Isolation of Extracellular Vesicles from Plasma Using a 2 mL Extracellular Vesicle SEC Column

The 2 mL Extracellular Vesicle SEC Column was loaded with 2 mL of human plasma. 500 μL fractions were collected and analyzed for particle and protein content by nanoparticle tracking analysis and bicinchoninic acid assays, respectively. EVs were detected in fractions 7 - 10, while proteins were detected in fractions 11 onwards.

Graphs showing the fractions in which particles and proteins, isolated from concentrated serum-free medium conditioned by mesenchymal stromal cell culture, using the 20 mL Extracellular Vesicle SEC Column, were detected by nanoparticle tracking analysis and bicinchoninic acid assays, respectively.

Figure 3. Isolation of Extracellular Vesicles from Conditioned Medium Using a 20 mL Extracellular Vesicle SEC Column

The 20 mL Extracellular Vesicle SEC Column was loaded with 20 mL of 10-fold concentrated serum-free medium conditioned by mesenchymal stromal cell (MSC) culture. 1 mL fractions were collected and analyzed for particle and protein content by nanoparticle tracking analysis and bicinchoninic acid assays, respectively. EVs were detected in fractions 15 - 30, while proteins were detected in fractions 35 onwards. Fractions 31-33, which are outside of the typical EV elution range, may still contain EVs with low protein contamination for serum-free media samples.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
100-0414
Lot #
All
Language
English
Catalog #
100-0415
Lot #
All
Language
English
Catalog #
100-0416
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.